Numeric Inconsistencies in the Results and Tables 3 and 5

• October 1, 2026

First MCT8 deficiency therapy approved

Clinical studies showed reductions in circulating thyroid hormone levels and changes in heart rate and systolic blood pressure.

• by Kathryn Wighton

• September 29, 2026

• 3 min

FDA approves new treatment for FOP

Total new heterotopic ossification volume decreased with treatment and increased with placebo at week 24.

• by Kathryn Wighton

• September 28, 2026

• 2 min

Erythropoietin for Neonatal Hypoxic-Ischemic Encephalopathy: A Randomized Clinical Trial

• by Helen G. Liley, Rod W. Hunt, Rachel L. O’Connell, Malcolm R. Battin, Iona Novak, Yvonne W. Wu, Roberta Ballard, Lisa Askie, Nadia Badawi, Alpana Ghadge, Susan E. Jacobs, Sandra E. Juul, Lucille Sebastian, Deepika Wagh, R. John Simes, PAEAN Study Investigators, Shannon Clough, Jennifer Bowen, Paul Colditz, Girsih Deshpande, Lisa Gold, Wendy Hague, Kei Lui, Dominic Wilkinson, Nicola Austin, Sarah Bellhouse, Max Berry, Clare Collins, Amanda Dyson, Antonio G de Paoli, Koert de Waal, Bevan Headley, Leah Hickey, James Holberton, David Hou, Alison L Kent, Vinayak Kodur, Richard Mausling, Scott Morris, Arun Nair, David Osborn, Victor Samuel Rajadurai, Nadia Schmidt, Jason Tan, Mark B Tracy, Flora Y Wong, Sarah Finlayson, Shannon Hunt, Carbo Yeung, Laurence Ralston

• October 1, 2026